The effect of screening on treatment cost: The case of colorectal cancer

Eline Aas ()

No 2008:5, HERO On line Working Paper Series from Oslo University, Health Economics Research Programme

Abstract: This paper presents a medical cost function developed for a screening programme. The medical cost function is a function of advancement both directly and indirectly through survival. We discuss how the medical cost function is affected by screening through a shift in the distribution of cancers according to advancement. We show that screening reduces the treatment cost for cancers diagnosed at the screening, even though the medical cost function not unambiguously increases with stage of advancement. This is the first step in a cost-effectiveness analysis, and even though the results are favourable to the introduction of screening for colorectal cancer as a preventive health measure, total screening costs and health benefits must be evaluated to arrive at a recommendation.

Keywords: treatment cost; stage of advancement; screening; probabilistic sensitivity analysis; bootstrap method (search for similar items in EconPapers)
JEL-codes: C41 H42 I10 I12 (search for similar items in EconPapers)
New Economics Papers: this item is included in nep-hea
Date: 2009-06-02

Downloads: (external link)
http://www.hero.uio.no/publicat/2008/2008_5.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:hhs:oslohe:2008_005

Access Statistics for this paper

More papers in HERO On line Working Paper Series from Oslo University, Health Economics Research Programme
Address: HERO / Institute of Health Management and Health Economics P.O. Box 1089 Blindern, N-0317 Oslo, Norway
Contact information at EDIRC.
Series data maintained by Gunn Kristin Tjoflot ().